XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]    
Schedule of Stock Option Activity

A summary of the Company’s outstanding stock option activity for the three months ended September 30, 2022, and 2021 is as follows:

 

       September 30, 2022     
      

Weighted-

Average

  

Weighted-

Average

Remaining

Contractual
Life

   Intrinsic 
   Options   Exercise Price   (Years)   Value 
As of December 31, 2021   8,339   $391    8.7    87,553 
Granted   3,570    45    10.0    - 
Exercised   -    -    -    - 
Forfeited   -    -    -    - 
Expired   -    -    -    - 
As of September 30, 2022   11,908   $238    8.4   $- 
Exercisable at September 30, 2022   5,373   $464    7.8   $- 
Vested and expected to vest at September 30, 2022   11,051   $248    8.4   $- 

 

       September 30, 2021     
      

Weighted-

Average

  

Weighted-

Average

Remaining

Contractual Life

   Intrinsic 
   Options   Exercise Price   (Years)   Value 
As of December 31, 2020   4,654   $553    9.3    511,518 
Granted   3,685    193    10.0    - 
Exercised   -    -    -    - 
Forfeited   -    -    -    - 
Expired   -    -    -    - 
As of September 30, 2021   8,339   $398    8.9   $417,164 
Exercisable at September 30, 2021   2,218   $1,226    8.6   $- 
Vested and expected to vest at September 30, 2021   8,339   $398    8.9   $417,164 

A summary of the Company’s outstanding stock option activity for the years ended December 31, 2021 and 2020 is as follows:

       December 31, 2021     
      

Weighted-

Average
Exercise

  

Weighted-

Average

Remaining

Contractual Life

   Intrinsic 
   Options   Price   (Years)   Value 
As of December 31, 2020   4,654   $553    9.3    511,518 
Granted   3,685    193    10.0    - 
Exercised   -    -    -    - 
Forfeited   -    -    -    - 
Expired   -    -    -    - 
As of December 31, 2021   8,339   $391    8.7   $87,553 
Exercisable at December 31, 2021   2,682   $1,004    8.3   $46,449 
Vested and expected to vest at December 31, 2021   8,303   $391    8.7   $86,703 

 

 

       December 31, 2020     
      

Weighted-

Average
Exercise

  

Weighted-

Average

Remaining

Contractual Life

   Intrinsic 
   Options   Price   (Years)   Value 
As of December 31, 2019   4   $744,669    5.3    - 
Granted   4,650    5    10.0    - 
Exercised   -    -    -    - 
Forfeited   -    -    -    - 
Expired   -    -    -    - 
As of December 31, 2020   4,654   $553    9.3   $511,518 
Exercisable at December 31, 2020   4   $697,742    4.3   $- 
Vested and expected to vest at December 31, 2020   4,654   $553    9.3   $511,518 
Schedule of Assumption Used for Fair value of Option

   September 30, 2022 
Weighted-average risk-free interest rate   1.70%
Weighted-average expected life (in years)   5.5 
Expected dividend yield   -%
Weighted-average expected volatility   131.1%

    Year Ended 
    December 31, 2021 
Weighted-average risk-free interest rate   0.73%-0.85 %
Weighted-average expected life (in years)   5.3-5.9  
Expected dividend yield   -%
Weighted-average expected volatility   138%-139 %
Schedule of Unrecognized Stock-based Compensation

Unrecognized stock-based compensation as of September 30, 2022, is as follows (in thousands):

 

      

Weighted

Average

 
  

Unrecognized

Stock-Based

  

Remaining of

Recognition

 
   Compensation   (in years) 
Stock options  $431    1.5 
Stock grants  $32    1.7 

Unrecognized stock-based compensation as of December 31, 2021, is as follows (in thousands):

       Weighted Average 
   Unrecognized Stock-Based   Remaining
of Recognition
 
   Compensation   (in years) 
Stock options  $531    1.9 
Stock grants  11    1.3